. Elucidating the interaction of LSD1 and the DNA damage machinery. (a, top) U2OS cells were treated with the ATM inhibitor KU55933 (15 µM), the ATR inhibitor as in Fig. S1 g, or with DMSO for 1 h. The cells were then irradiated (5 Gy) and incubated at 37°C for 1 h, and whole cell extracts were Western blotted for phosphorylated Kap1 (an ATM target) or phosphorylated Chk1 (an ATR target). (bottom) U2OS cells were treated with the PARP inhibitor KU58948 (2 µM) or with DMSO for 1 h. The cells were then laser microirradiated and stained for poly-ADP-ribose (PAR) and pH2A.X. (b) U2OS cells stably expressing HA-tagged LSD1 were laser microirradiated after treatment with the PARP inhibitor KU58948 (2 µM) or with DMSO for 1 h. The cells were subsequently stained for HA-LSD1 and pH2A.X. Bars, 20 µm. (c) Quantitation of panel b, with error bars representing the SD of triplicate experiments. (d) U2OS cells were infected with the indicated lentiviral shRNAs and whole cell extracts were Western blotted with the indicated antibodies. (e) Immunoprecipitation was performed from 293T cells mock infected or stably expressing Flag-HA-RNF168, with or without synchronization in G2/M with nocodazole, followed by Western blotting as indicated. (f) Immunoprecipitation was performed from HeLa nuclear extract using equal amounts of an antibody against RNF168 or a control IgG. Input and immunoprecipitated material were analyzed by Western blotting using the indicated antibodies. (g) Immunoprecipitation was performed from 293T cells expressing Flag-vector or Flag-LSD1, in combination with GFP-tagged wild-type RNF168 or a catalytically inactive mutant form (C16S) of RNF168 as indicated. Input and immunoprecipitated material were analyzed by Western blotting as indicated. Peptide numbers of proteins found by MS/MS analysis of the Flag-RNF168 complex purified from 293T nuclear extract, with or without prior -IR (10 Gy). All proteins with ≥10 total peptides for both samples are shown. 
